A smartphone app to monitor Parkinson's disease symptoms
NeuroVision™: A Smartphone Application for Neurology and Telemedicine
This study is testing a smartphone app that helps people with Parkinson's disease track their symptoms, like tremors and slow movements, to make it easier for them and their doctors to monitor their condition from home.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 35 Years and up |
| Sex | All |
| Sponsor | Altec Inc. Industry-sponsored |
| Locations | 1 site (Natick, Massachusetts) |
| Trial ID | NCT06245174 on ClinicalTrials.gov |
What this trial studies
This observational research aims to assess the feasibility of a new software application designed for smartphones and tablets that measures abnormal body movements associated with Parkinson's disease (PD) using a commercially available camera. The NeuroVision App will facilitate remote monitoring of PD symptoms during telehealth appointments by capturing motor outcomes through standardized assessment tasks. These tasks include observing tremors, bradykinesia, and akinesia, which will be validated against a reference motion capture system. The goal is to enhance the accuracy of symptom assessment in a home setting, making it more convenient for patients and clinicians alike.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 35 and older with physician-diagnosed Parkinson's disease or other movement disorders, exhibiting mild to moderate motor symptoms.
Not a fit: Patients who are unable to understand spoken English or follow simple instructions may not benefit from this study.
Why it matters
Potential benefit: If successful, this app could significantly improve the monitoring and management of Parkinson's disease symptoms for patients in a telehealth setting.
How similar studies have performed: While the approach of using smartphone technology for monitoring movement disorders is emerging, this specific application and methodology are relatively novel and have not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or Female; * 35 years of age or older; * Physician-diagnosed Parkinson's disease or other movement disorder such as Essential Tremor or Dystonia; * One or more mild to moderate motor symptoms of PD (tremor, bradykinesia, akinesia, Parkinsonian gait); * Hohn and Yahr (Stage I-III); * Independent ambulator - walker or cane allowed; * Referring neurologist indicates that prospective subject is not at high fall risk and can safely participate in the study; * Have participated in prior telehealth visits using videoconferencing app; * Have used a smartphone in past to record videos; * Able to provide his/her written informed consent to participate in the study as stated in the informed consent document; * American-English speaking; able to follow directions in English; * Normal hearing. Exclusion Criteria: * Inability to understand spoken English or follow simple instructions; * Inability to provide written informed consent.
Where this trial is running
Natick, Massachusetts
- Altec Inc. — Natick, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Bhawna Shiwani, MS — Senior Research Scientist
- Study coordinator: Bhawna Shiwani, MS
- Email: bshiwani@altecresearch.com
- Phone: (508)545-8217
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.